Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
BULLISH SIGNAL DETECTED
██.█% Sign up free to reveal

Baxter International Inc (BAX) AI Forecast

Our AI detected a significant signal for Baxter International Inc. Create a free account to see the exact price target.

✓ Free account • ✓ 30-day free trial

$BAX Bullish Signal Full forecast available
Sign Up Free

Baxter International Inc (BAX) Stock Forecast 2025

Baxter International Inc (BAX) AI Stock Price Forecast & Investment Analysis

Baxter International Inc Stock Price Chart and Technical Analysis

Loading chart...

Baxter International Inc (BAX) - Comprehensive Stock Analysis & Investment Research

Deep dive into Baxter International Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on July 12, 2026, 3:16 a.m. (UTC)

Baxter International Inc Investment Summary

When evaluating whether Baxter International Inc (BAX) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Baxter International Inc (BAX) operates within the Industrial Applications and Services sector, specifically in the Surgical & Medical Instruments & Apparatus industry. . With a market capitalization of $12 billion, the company is a large-cap stock offering relative stability combined with growth potential.

Financial Performance Analysis

Our comprehensive financial analysis covers Baxter International Inc's revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Baxter International Inc along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Baxter International Inc is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Baxter International Inc

Sign Up Free
Corporate Identity

Baxter International Inc (Stock Symbol: BAX) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Surgical & Medical Instruments & Apparatus industry. The company's shares are publicly traded on the NYSE exchange.

Leadership & Workforce

Detailed information about Baxter International Inc's leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Baxter International Inc...

Sector & Industry Analysis

In-depth sector dynamics and industry context for Baxter International Inc...

Unlock Full Company Profile

Get complete details about Baxter International Inc

Sign Up Free
Revenue & Growth Analysis

Baxter International Inc generates annual revenues of $11 billion , demonstrating substantial market presence and operational scale.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Baxter International Inc...

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Baxter International Inc...

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Baxter International Inc...

Unlock Financial Analysis

Get complete financial metrics for Baxter International Inc

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Baxter International Inc's AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Baxter International Inc strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace. As a large-cap market participant, the company has established significant competitive advantages and market presence. Large-cap companies typically benefit from brand recognition, operational scale, diverse revenue streams, and the financial resources to invest in research and development, marketing, and strategic acquisitions. This size category attracts substantial institutional ownership and analyst coverage.

Industry Competitive Landscape

Baxter International Inc competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency
Margin & Pricing Power Analysis

The company maintains a 52.6% gross margin indicating healthy pricing power relative to direct production costs. This margin level suggests the company has successfully differentiated its products or services, allowing it to command prices meaningfully above input costs. Maintaining these margins requires ongoing investment in brand, technology, or other differentiating factors.

Asset Utilization Efficiency

Asset turnover ratio of 0.57x indicates moderate asset turnover common in capital-intensive industries such as utilities, real estate, or heavy manufacturing. Lower turnover in these sectors is expected due to the significant infrastructure required for operations.

Financial Strength & Leverage

Baxter International Inc (BAX) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Baxter International Inc stock analysis.

Deep dive into Baxter International Inc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Baxter International Inc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Baxter International Inc:

P/B Ratio 1.93x
Market Cap $11.65B
Dividend Yield 2.28%
EPS $7.16
Book Value/Share $11.73
Revenue/Share $21.98
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Baxter International Inc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Baxter International Inc: An ROE of 73.0% demonstrates excellent shareholder value creation.

ROE 73.0%
ROA 22.2%
Gross Margin 52.6%
Net Margin 18.6%
EBT Margin 22.9%
Tax Rate 18.7%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Baxter International Inc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Baxter International Inc:

D/E Ratio 2.29x
Financial Leverage 3.28x
Interest Coverage -2.5x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Baxter International Inc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Baxter International Inc:

Operating Cash Flow $4.19B
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Baxter International Inc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Baxter International Inc: An asset turnover of 0.57x suggests room for improvement in asset utilization.

Asset Turnover 0.57x
Understanding Financial Statement Data

What these metrics mean: Key figures from Baxter International Inc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Baxter International Inc: With annual revenue of $11320M, Baxter International Inc operates at significant scale.

Income Statement
Total Revenue $11.32B
Net Income $4.41B
R&D Expense $1.77B
SG&A Expense $5.08B
Cost of Goods Sold $11.28B
Balance Sheet Highlights (% Of Assets)
Total Liabilities 13830%
Dividend & Shareholder Information
Dividends Per Share $0.52
Shares Outstanding 515M
Growth Metrics (YoY)
Net Income Growth 18.6%
EPS Growth 31.7%

Latest Baxter International Inc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Baxter International Inc (BAX) stock price and investment outlook.

source: Yahoo Finance

Is BAX a good stock to buy? We came across a bullish thesis on Baxter International Inc. on Heavy Moat Investments’s Substack. In this article, we will summarize the bulls’ thesis on BAX. Baxter ...

More news available

Sign up free to read all 10 news articles and stay updated on market developments.

Sign Up Free to Read More

Baxter International Inc Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Baxter International Inc against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Adagio Medical Holdings, Inc. ADGM ██% $13M x 2.2x
Aethlon Medical Inc AEMD ██% $2M x 0.4x
Acutus Medical, Inc. AFIB ██% $0.00M 0.0x -0.4x
Allurion Technologies, Inc. ALUR ██% $6M x x
Autonomix Medical, Inc. AMIX ██% $4M x 0.6x
Angiodynamics Inc ANGO ██% $533M x 3.1x
Anika Therapeutics, Inc. ANIK ██% $208M x 1.6x
Artivion, Inc. AORT ██% $1.16B 99.1x 2.6x
Apyx Medical Corp APYX ██% $183M x 14.3x
Accuray Inc ARAY ██% $29M x 0.7x
Alphatec Holdings, Inc. ATEC ██% $1.47B x x
Atricure, Inc. ATRC ██% $1.74B x 3.5x
Nuo Therapeutics, Inc. AURX ██% $46M x x
Avita Medical, Inc. AVHHL ██% $22M x x
Baxter International Inc BAX ██% $11.65B x 1.9x
Beta Bionics, Inc. BBNX ██% $759M x 2.8x
Becton Dickinson & Co BDX ██% $41.87B 36.8x 1.7x
Heartbeam, Inc. BEAT ██% $34M x 52.9x
Bluejay Diagnostics, Inc. BJDX ██% $2M x 0.4x
Boston Scientific Corp BSX ██% $66.48B 18.7x 2.6x
Biotricity Inc. BTCY ██% $3M x x
Bioventus Inc. BVS ██% $799M 28.1x 4.2x
Brainsway Ltd. BWAY ██% $604M x x
Carlsmed, Inc. CARL ██% $323M x 3.5x
Cerus Corp CERS ██% $606M x 9.0x
Clearpoint Neuro, Inc. CLPT ██% $525M x 27.9x
Co-Diagnostics, Inc. CODX ██% $10M x 0.6x
Cytosorbents Corp CTSO ██% $24M x 10.9x
Cvrx, Inc. CVRX ██% $144M x 4.9x
Delcath Systems, Inc. DCTH ██% $448M 799.3x 4.0x
Dih Holding Us, Inc. DHAI ██% $70K x -0.3x
Dariohealth Corp. DRIO ██% $53M x 0.8x
Alpha Tau Medical Ltd. DRTS ██% $1.12B x 14.5x
Dexcom Inc DXCM ██% $28.93B 31.1x 9.8x
Dynatronics Corp DYNT ██% $540K -0.2x 0.2x
Dynatronics Corp DYNTQ ██% $0.00M x 0.0x
Ebr Systems, Inc. EBRCZ ██% $137M x 14.4x
Encision Inc ECIA ██% $3M x 1.8x
Embecta Corp. EMBC ██% $192M 1.7x x
Electromedical Technologies, Inc EMED ██% $750K x x
Femasys Inc FEMY ██% $12M x 1.7x
Family Office Of America, Inc. FOFA ██% $27M 173.9x 28.2x
Glucotrack, Inc. GCTK ██% $3M x x
Global Innovative Platforms Inc. GIPL ██% $170K x 0.3x
Glaukos Corp GKOS ██% $8.91B x 13.3x
Globus Medical Inc GMED ██% $10.57B 18.0x 2.2x
Fractyl Health, Inc. GUTS ██% $126M x 5.9x
Haemonetics Corp HAE ██% $3.45B 35.4x 4.3x
Harvard Apparatus Regenerative Technology, Inc. HRGN ██% $18M x 200.7x
Heartflow, Inc. HTFL ██% $2.30B x 8.1x
Integra Lifesciences Holdings Corp IART ██% $1.45B x 1.4x
Icecure Medical Ltd. ICCM ██% $12M x 1.3x
Seastar Medical Holding Corp ICU ██% $88M -1.1x 7.7x
Icu Medical Inc/De ICUI ██% $3.86B 83.3x 1.8x
Interpace Biosciences, Inc. IDXG ██% $45M 1.9x 2.0x
Qtrex Quantum Ltd. IINN ██% $132M x 56.7x
Inspira Technologies Oxy B.H.N. Ltd IINNW ██% $7M x 1.5x
Intelligent Bio Solutions Inc. INBS ██% $5M x 0.6x
Infusystem Holdings, Inc INFU ██% $169M 30.5x 3.0x
Inspire Medical Systems, Inc. INSP ██% $1.49B 11.4x 1.9x
Iradimed Corp IRMD ██% $1.24B 52.6x 12.6x
Irhythm Holdings, Inc. IRTC ██% $3.82B x 23.7x
Invo Fertility, Inc. IVF ██% $2M x 0.1x
Orthopediatrics Corp KIDS ██% $482M x 1.4x
Kestra Medical Technologies, Ltd. KMTS ██% $1.52B x 5.3x
Koru Medical Systems, Inc. KRMD ██% $197M x 11.7x
Lemaitre Vascular Inc LMAT ██% $2.35B 37.6x 5.8x
Lensar, Inc. LNSR ██% $73M 2.5x 6.7x
Lucid Diagnostics Inc. LUCD ██% $191M x 47.7x
Pulmonx Corp LUNG ██% $65M x 1.4x
Lyra Therapeutics, Inc. LYRA ██% $960K x x
Microbot Medical Inc. MBOT ██% $127M x 1.7x
Mountain Crest Acquisition Corp. V MCAG ██% $37M x x
Mountain Crest Acquisition Corp. V MCAGU ██% $31M x -9.9x
Spectral Ai, Inc. MDAI ██% $55M x x
Medline Inc. MDLN ██% $73.59B 87.9x 6.5x
Medinotec Inc. MDNC ██% $59M 65.1x 10.0x
Mimedx Group, Inc. MDXG ██% $612M 19.9x 2.5x
Monogram Technologies Inc. MGRM ██% $217M -10.7x 25.1x
Meihua International Medical Technologies Co., Ltd. MHUA ██% $151M x 0.9x
3m Co MMM ██% $82.16B 29.5x 25.2x
Merit Medical Systems Inc MMSI ██% $4.38B 31.4x 2.7x
Modular Medical, Inc. MODD ██% $22M x 1.7x
Nephros Inc NEPH ██% $39M 50.7x 3.7x
Neuroone Medical Technologies Corp NMTC ██% $25M x 4.9x
Neuropace Inc NPCE ██% $580M x 40.1x
Inspiremd, Inc. NSPR ██% $34M x 0.8x
Nu-Med Plus, Inc. NUMD ██% $1M x x
Novocure Ltd NVCR ██% $1.89B x 5.7x
Envveno Medical Corp NVNO ██% $7M x 0.3x
Nexgel, Inc. NXGL ██% $4M x 1.1x
Nyxoah Sa NYXH ██% $175M x x
Orchestra Biomed Holdings, Inc. OBIO ██% $234M x 5.7x
Odyssey Health, Inc. ODYY ██% $710K x x
Orthofix Medical Inc. OFIX ██% $470M x 1.1x
Osr Health, Inc. OSRH ██% $11M x 0.1x
Orasure Technologies Inc OSUR ██% $298M x 1.0x
Pavmed Inc. PAVM ██% $40M x 1.0x
Pro Dex Inc PDEX ██% $201M 16.8x 4.5x
Penumbra Inc PEN ██% $12.49B 73.0x 8.5x
Petvivo Holdings, Inc. PETV ██% $29M x 13.0x
Profusa, Inc. PFSA ██% $1M x x
Polyrizon Ltd. PLRZ ██% $27M x 1.1x
Pulse Biosciences, Inc. PLSE ██% $1.79B x 27.1x
Picard Medical, Inc. PMI ██% $16M x 4.2x
Insulet Corp PODD ██% $11.29B 37.3x 8.7x
Procept Biorobotics Corp PRCT ██% $1.19B x 3.4x
Premier Air Charter Holdings Inc. PREM ██% $2M x 0.7x
Profound Medical Corp. PROF ██% $256M x 4.3x
Plus Therapeutics, Inc. PSTV ██% $28M x 2.3x
Polypid Ltd. PYPD ██% $95M x 8.7x
Qtrex Quantum Ltd. QTEX ██% $90M x 38.6x
Avita Medical, Inc. RCEL ██% $125M x x
Vivos Inc RDGL ██% $40M x 14.7x
Resmed Inc RMD ██% $29.57B 19.5x 4.6x
Resmed Inc RSMDF ██% $3.82B 2.7x 0.6x
Retinalgenix Technologies Inc. RTGN ██% $75M x x
Retractable Technologies Inc RVP ██% $21M x 0.3x
Sight Sciences, Inc. SGHT ██% $287M x 5.3x
Spyglass Pharma, Inc. SGP ██% $753M x 3.0x
Si-Bone, Inc. SIBN ██% $776M x 4.3x
Sigyn Therapeutics, Inc. SIGY ██% $40K x x
Sintx Technologies, Inc. SINT ██% $11M x 12.1x
Skinhealth Systems Inc. SKIN ██% $118M x 2.1x
Sonoma Pharmaceuticals, Inc. SNOA ██% $6M x 2.0x
Sanuwave Health, Inc. SNWV ██% $100M 6.3x 54.6x
Solventum Corp SOLV ██% $13.31B 9.3x 2.7x
Sensus Healthcare, Inc. SRTS ██% $50M x 1.1x
Ss Innovations International, Inc. SSII ██% $758M x 13.9x
Strata Skin Sciences, Inc. SSKN ██% $530K x 0.2x
Neuronetics, Inc. STIM ██% $122M x 9.2x
Stimcell Energetics Inc. STME ██% $6M x x
Skyai, Inc. STSS ██% $61M x 0.3x
Stevanato Group S.P.A. STVN ██% $5.35B x x
Stryker Corp SYK ██% $126.42B 37.9x 5.5x
Tactile Systems Technology Inc TCMD ██% $677M 33.4x 3.1x
Tela Bio, Inc. TELA ██% $38M x x
Teleflex Inc TFX ██% $6.01B x 2.0x
Trisalus Life Sciences, Inc. TLSI ██% $254M x 19.9x
Trisalus Life Sciences, Inc. TLSIW ██% $62M x -1.9x
Treace Medical Concepts, Inc. TMCI ██% $279M x 3.6x
Tandem Diabetes Care Inc TNDM ██% $1.06B x 8.0x
Tenon Medical, Inc. TNON ██% $4M x 2.1x
T2 Biosystems, Inc. TTOO ██% $210K 0.0x -0.3x
Ufp Technologies Inc UFPT ██% $1.83B 26.7x 4.2x
Qhslab, Inc. USAQ ██% $4M 9.2x 2.6x
Utah Medical Products Inc UTMD ██% $216M 20.0x 1.8x
Venus Concept Inc. VERO ██% $580K x 0.2x
Catheter Precision, Inc. VTAK ██% $3M x 0.3x
Vivos Therapeutics, Inc. VVOS ██% $6M x x
Vycor Medical Inc VYCO ██% $2M x x
West Pharmaceutical Services Inc WST ██% $25.08B 46.2x 8.4x
Beyond Air, Inc. XAIR ██% $300K x 0.1x
Xtant Medical Holdings, Inc. XTNT ██% $59M 32.2x 1.2x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Baxter International Inc Stock Forecast

How accurate are Baxter International Inc stock predictions?

Our AI model shows a -5% Spearman correlation coefficient for BAX predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Baxter International Inc stock price forecasts?

Our analysis considers Baxter International Inc's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Baxter International Inc a good investment in 2025?

Based on our AI analysis, Baxter International Inc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Baxter International Inc forecasts updated?

Baxter International Inc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Baxter International Inc?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...